Scientists discover how antibiotic molecule found in bacteria stops breast cancer

August 22, 2011 in Cancer

(Medical Xpress) -- Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread, reveals research published in Nature Chemistry today.

Scientists at Cancer Research UK’s Cambridge Research Institute, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and The University of Cambridge, have revealed at the molecular level how thiostrepton - a naturally-occurring cancer-protector molecule - ‘clamps’ a cancer-causing called FOXM1, preventing it from working.

FOXM1 is present in greater amounts in cells. It attaches to specific stretches of DNA - switching on genes regulating the growth and division of cells. It also causes tumours to spread and triggers the growth of blood vessels which supply tumours with nutrients for growth.

Blocking this protein may prevent the development of cancer at an early stage as well as block cancer growth and spread.

Designing drugs to stop proteins like FOXM1 is a huge challenge for scientists. But this new information will allow researchers to design small that mimic thiostrepton – but are even more effective at blocking the cancer-promoting effects of FOXM1.

Lead author, Professor Shankar Balasubramanian, based at Cancer Research UK’s Cambridge Research Institute, said: “Before this research we weren’t aware of any natural product which could directly target a protein that controls gene activity. Yet intriguingly a molecule in - which also has strong antibiotic effects - does this very well, switching off cancer-causing genes in breast cancer cells.

“This naturally-occurring molecule doesn’t have all the right properties to be used as a breast cancer treatment itself. But this exciting discovery paves the way for the design of more potent and selective drugs based on the structure of thiostrepton to block the FOXM1 protein.”

Around 48,000 women in the UK are diagnosed with breast cancer each year and around 12,100 UK women die from the disease.

Dr Lesley Walker, Cancer Research UK’s director of cancer information, said: “Survival rates for breast cancer have been improving for 30 years thanks to the development of more targeted treatments. But there is more to be done. One huge challenge is how to prevent breast cancer from spreading to other parts of the body – once a cancer has spread it becomes more difficult to treat successfully.

“It’s fascinating to discover how a simple bacteria could hold the key to powerful new approaches to treat breast cancer developing and spreading.”

More information: The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Hegde et al. Nature Chemistry.

Provided by Cancer Research UK

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Anti-CD47 antibody may offer new route to successful cancer vaccination

(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...

Cancer created 32 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Older prostate cancer patients should think twice before undergoing treatment

Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...

Cancer created 14 hours ago | popularity not rated yet | comments 0 | with audio podcast

Two radiotherapy treatments show similar morbidity, cancer control after prostatectomy

Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina suggests that the therapy may not be more effective than older, ...

Cancer created 15 hours ago | popularity not rated yet | comments 0

The compound in the Mediterranean diet that makes cancer cells 'mortal'

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...

Cancer created 16 hours ago | popularity 4.8 / 5 (13) | comments 3 | with audio podcast

CT radiation risk less than risk of examination indicator

(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...

Cancer created 17 hours ago | popularity not rated yet | comments 0


Sugar injections for knee arthritis may ease pain

(HealthDay)—Injections of a sugar solution appear to help relieve knee pain and stiffness related to osteoarthritis, a new study suggests.

Evaluating a new way to open clogged arteries

Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...

Losing weight may ease chronic heartburn

(HealthDay)—Obese and overweight men and women who suffer from heartburn often report relief when they lose weight, a new study shows.

Primary care docs should play role in kids' dental health, experts say

(HealthDay)—When it comes to the care of your children's teeth, dentists aren't the only experts who can help.

ATS: Early prone positioning reduces mortality in ARDS

(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), prolonged prone positioning during mechanical ventilation is associated with significantly reduced mortality at 28 and 90 days, ...

Tunisia announces three cases of coronavirus, one death

(AP)—Tunisia's Health Ministry says a 66-year-old man has died after being infected by the new coronavirus following a visit to Saudi Arabia.